Soleno Therapeutics, Inc.

SLNO

$62.11

Name : Soleno Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $3,300,836,352.00

EPSttm : -4.48

Soleno Therapeutics, Inc.

$62.11

6.26%

$3.66

Float Short %

15.75

Margin Of Safety %

Put/Call OI Ratio

1.03

EPS Next Q Diff

0.3

EPS Last/This Y

3.69

EPS This/Next Y

3.71

Price

62.1

Target Price

119

Analyst Recom

1.08

Performance Q

-29.81

Relative Volume

0.7

Beta

-2.91

Ticker: SLNO

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	SLNO	72.3	1.22	10.09	39673
2025-09-09	SLNO	69.85	1.22	0.01	39668
2025-09-10	SLNO	60.01	1.20	0.84	39977
2025-09-11	SLNO	56.68	1.15	0.81	47665
2025-09-12	SLNO	53.66	1.12	0.57	50335
2025-09-15	SLNO	51.94	1.03	0.39	50786
2025-09-16	SLNO	49.5	0.98	0.23	54424
2025-09-17	SLNO	50.98	0.85825396302277	0.81576477948076	56385
2025-09-18	SLNO	56.26	0.83	1.18	61216
2025-09-19	SLNO	54.72	0.82	1.34	61501
2025-09-22	SLNO	56.52	1.06	4.85	54677
2025-09-23	SLNO	56.66	1.06	0.65	54942
2025-09-24	SLNO	64.18	1.06	0.98	55122
2025-09-25	SLNO	62.75	1.11	2.28	56066
2025-09-26	SLNO	64.75	1.11	2.76	56329
2025-09-29	SLNO	68.2	1.13	0.49	56963
2025-09-30	SLNO	67.91	1.18	2.58	56310
2025-10-01	SLNO	60.04	1.19	1.11	56408
2025-10-02	SLNO	57.84	1.16	1.16	61209
2025-10-03	SLNO	59.17	1.17	0.11	63981
2025-10-06	SLNO	58.5	1.06	0.08	67428
2025-10-07	SLNO	62.4	1.03	0.61	68439
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	SLNO	72.30	-	-	-0.69
2025-09-09	SLNO	70.18	-	-	-0.69
2025-09-10	SLNO	60.22	-	-	-0.69
2025-09-11	SLNO	56.72	-	-	-0.69
2025-09-12	SLNO	53.64	-	-	-0.69
2025-09-15	SLNO	51.17	-	-	-0.70
2025-09-16	SLNO	49.71	-	-	-0.70
2025-09-17	SLNO	50.95	-	-	-0.70
2025-09-18	SLNO	56.58	-	-	-0.70
2025-09-19	SLNO	54.70	-	-	-0.70
2025-09-22	SLNO	56.58	-	-	-0.70
2025-09-23	SLNO	56.80	-	-	-0.70
2025-09-24	SLNO	64.63	-	-	-0.70
2025-09-25	SLNO	62.72	-	-	-0.70
2025-09-26	SLNO	64.96	-	-	-0.70
2025-09-29	SLNO	68.18	-	-	-0.70
2025-09-30	SLNO	67.65	-	-	-0.70
2025-10-01	SLNO	59.97	-	-	-0.70
2025-10-02	SLNO	57.85	-	-	-0.70
2025-10-03	SLNO	59.17	-	-	-0.70
2025-10-06	SLNO	58.50	-	-	-0.70
2025-10-07	SLNO	62.10	-	-	-0.69
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	SLNO	-29.13	13.98	13.72
2025-09-09	SLNO	-29.13	13.98	13.72
2025-09-10	SLNO	-29.13	13.98	13.72
2025-09-11	SLNO	-29.13	13.98	16.49
2025-09-12	SLNO	-29.13	13.98	16.48
2025-09-15	SLNO	-29.28	14.00	16.48
2025-09-16	SLNO	-29.28	14.00	16.48
2025-09-17	SLNO	-29.28	14.00	16.48
2025-09-18	SLNO	-29.28	14.00	16.48
2025-09-19	SLNO	-29.28	14.00	16.48
2025-09-22	SLNO	-29.28	14.00	16.48
2025-09-23	SLNO	-29.28	14.00	16.48
2025-09-24	SLNO	-29.28	14.00	16.48
2025-09-25	SLNO	-29.28	14.00	15.75
2025-09-26	SLNO	-29.28	14.00	15.75
2025-09-29	SLNO	-13.54	14.19	15.75
2025-09-30	SLNO	-13.54	14.19	15.75
2025-10-01	SLNO	-0.11	14.19	15.75
2025-10-02	SLNO	-0.11	14.19	15.75
2025-10-03	SLNO	-0.06	14.19	15.75
2025-10-06	SLNO	-0.06	15.44	15.75
2025-10-07	SLNO	-0.06	15.44	15.75
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.09

Avg. EPS Est. Current Quarter

0.04

Avg. EPS Est. Next Quarter

0.21

Insider Transactions

-0.06

Institutional Transactions

15.44

Beta

-2.91

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

31.2

Max Drawdown 5-Year %

-98.2

Target Price

119

P/E

Forward P/E

20.34

PEG

P/S

101.07

P/B

13.05

P/Free Cash Flow

EPS

-4.15

Average EPS Est. Cur. Y

-0.69

EPS Next Y. (Est.)

3.02

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-554.49

Relative Volume

0.7

Return on Equity vs Sector %

-100.6

Return on Equity vs Industry %

-86.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

Soleno Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 133

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.

stock quote shares SLNO – Soleno Therapeutics Inc Stock Price stock today

news today SLNO – Soleno Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch SLNO – Soleno Therapeutics Inc yahoo finance google finance

stock history SLNO – Soleno Therapeutics Inc invest stock market

stock prices SLNO premarket after hours

ticker SLNO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: SLNO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y